Allergan spins off ophthalmic device businesses
This article was originally published in Clinica
Executive Summary
Eyecare company Allergan is to spin off its ophthalmic surgical and contact lens businesses to form an independent, public company, in order to focus on the more profitable specialty pharmaceutical business. The new company, which will be called Advanced Medical Optics (AMO), plans a New York listing.